The fragmentation procedure uses the femtosecond laser to split the cataractous lens into sections. This is followed by phacoemulsification for cataract removal.
Bausch + Lomb claims that the Victus platform offers a number of different lens fragmentation patterns depending on the cataract grade and user preference.
The VICTUS platform had received CE mark approval in November 2011 and the FDA approval in July 2012. This platform received additional CE Mark approvals including Intracor treatment used for flapless intrastromal correction, corneal incisions, penetrating keratoplasty and the creation of intrastromal channel incisions for intracorneal ring segments.
Bausch + Lomb chief medical officer Calvin Roberts said: "Bausch + Lomb has made great progress building out a comprehensive and competitive product portfolio for ophthalmic surgeons, and today’s lens fragmentation clearance on the VICTUS platform further strengthens our offerings.
"For cataract, refractive or retinal surgery, the more you look at Bausch + Lomb, the more you’ll see that we have the platforms, intraocular lenses, instruments, packs, and distribution partnerships that together are helping improve patients’ vision and eye health."
